Hypertension induced by immunosuppressive drugs: a comparative analysis between sirolimus and cyclosporine.
about
Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitorsEffects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney DiseaseThe novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cells.Oxazolone-induced delayed type hypersensitivity reaction in the adult yucatan pigs. A useful model for drug development and validationRapamune does not attenuate high cholesterol-induced atherosclerosis in rabbits.Cardiorenal benefits of early versus late cyclosporine to sirolimus conversion in a rat model.Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.Inhibition of Mammalian Target of Rapamycin Complex 1 Attenuates Salt-Induced Hypertension and Kidney Injury in Dahl Salt-Sensitive Rats.Role of mechanistic target of rapamycin (mTOR) in renal function and ischaemia-reperfusion induced kidney injury.Effects of everolimus on cytokines, oxidative stress, and renal histology in ischemia-reperfusion injury of the kidney.Rapamycin exacerbates cardiovascular dysfunction after complete high-thoracic spinal cord injury.Comprehensive review of cardiovascular toxicity of drugs and related agents.
P2860
Q26823023-99ACD29A-525E-431B-8414-B31856B134C5Q27320627-5EFD9FC7-015D-44E1-A513-2A07AB15CBACQ30318847-DD8666E4-6BB4-4162-B5EA-285C07F9B353Q30429819-F87EFC87-0FC4-4C5D-AEF6-B5FCC2D8791AQ33848041-02EEB227-BA3A-487E-88E4-102CA192D634Q35975228-D56FFB6B-CE72-4EB3-8ACD-079C703D59A5Q37760379-AAE285E9-14FB-4EEF-B540-224956FC5B2EQ38615411-1AF29C06-4477-4DAF-82FD-BD4E304C961FQ39459761-93FB9486-0FAD-4B58-A1FC-F7D8D791C789Q43265105-1A024C97-08C6-4588-BB29-492780201B54Q47368760-762EEC67-D39A-4594-B537-76A164F9E229Q47556269-EEFE3547-0C3B-4C96-83B2-0EB6BABF3200
P2860
Hypertension induced by immunosuppressive drugs: a comparative analysis between sirolimus and cyclosporine.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Hypertension induced by immuno ...... en sirolimus and cyclosporine.
@en
Hypertension induced by immuno ...... en sirolimus and cyclosporine.
@nl
type
label
Hypertension induced by immuno ...... en sirolimus and cyclosporine.
@en
Hypertension induced by immuno ...... en sirolimus and cyclosporine.
@nl
prefLabel
Hypertension induced by immuno ...... en sirolimus and cyclosporine.
@en
Hypertension induced by immuno ...... en sirolimus and cyclosporine.
@nl
P2093
P50
P1476
Hypertension induced by immuno ...... en sirolimus and cyclosporine.
@en
P2093
A Figueiredo
E Teixeira de Lemos
P Eufrásio
S Baptista
P304
P356
10.1016/J.TRANSPROCEED.2009.02.005
P407
P50
P577
2009-04-01T00:00:00Z